Biography
Andrew comes to Abcentra with nearly 20 years of commercial, financial, and strategy experience. Most recently he led Novo Nordisk’s North American Commercial Pipeline Team responsible for early asset development in the Cardiovascular and Chronic Kidney Disease therapy areas. Additionally, he has served as a strategic advisor and support for the Head of North America (NA) and the NA Executive Team.
Previously, Andrew was the co-founder and CFO of High Resolution Energy, an early-stage hedge fund focused on developing proprietary trading algorithms, and was a consultant with Accenture.
Andrew received his BS from Boston University and MBA from University of Michigan.
